Cargando…
Biomarkers for Early Detection of Malignant Mesothelioma: Diagnostic and Therapeutic Application
Malignant mesothelioma (MM) is a rare and aggressive tumour of the serosal cavities linked to asbestos exposure. Improved detection methods for diagnosing this type of neoplastic disease are essential for an early and reliable diagnosis and treatment. Thus, focus has been placed on finding tumour ma...
Autores principales: | Tomasetti, Marco, Santarelli, Lory |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Molecular Diversity Preservation International
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3835090/ https://www.ncbi.nlm.nih.gov/pubmed/24281081 http://dx.doi.org/10.3390/cancers2020523 |
Ejemplares similares
-
ATG5 as biomarker for early detection of malignant mesothelioma
por: Tomasetti, Marco, et al.
Publicado: (2023) -
Epigenetic Regulation of miRNA Expression in Malignant Mesothelioma: miRNAs as Biomarkers of Early Diagnosis and Therapy
por: Tomasetti, Marco, et al.
Publicado: (2019) -
Exosome-derived microRNAs in cancer metabolism: possible implications in cancer diagnostics and therapy
por: Tomasetti, Marco, et al.
Publicado: (2017) -
Diagnostic and Therapeutic Challenges of Malignant Pleural Mesothelioma
por: Moro, Jacopo, et al.
Publicado: (2022) -
MicroRNA in Metabolic Re-Programming and Their Role in Tumorigenesis
por: Tomasetti, Marco, et al.
Publicado: (2016)